Facebook Inc (NASDAQ FB) is mad at the United States Drug Enforcement Administration for creating fake accounts to catch drug offenders. The social media giant sent a formal complaint to the DEA. Facebook recently sent a letter to the DEA asking them to stop impersonating users. The letter comes from Joe Sullivan (Facebook’s security chief…
Nike chief executive Mark Parker has hinted at a future collaboration with Apple on a new item of wearable technology, which will be more “stealth” than existing products. Since 2006 the two companies have partnered on wearable technology, with their first attempt marked by the Nike+ running which was released in 2006 and connected wirelessly…
Pharmacyclics (PCYC) announced that it has teamed up with Roche (RHHBY) for evaluating the safety, tolerability and preliminary efficacy of its oncology treatment, Imbruvica, in combination with the latter’s Gazyva. The companies will assess the cocktail therapy in patients with non-hodgkin lymphoma (NHL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in multiple clinical trials. As…
A Florida law firm is pressing charges against digital currency exchange Cryptsy, accusing the company of fraudulent business practices and negligent security measures. In court documents filed in the 15th Judicial Court of Florida yesterday, Silver Law Firm stated that Cryptsy violated the state’s Deceptive and Unfair Trade Practices Act by failing to provide critical…
Shares of Microsoft Corporation climbed by as much as 3% in after-hours trading. Microsoft Corporation (NASDAQ MSFT) released the earnings results from its most recently completed quarter tonight after closing bell, posting non-GAAP earnings of 65 cents per share on $23.2 billion in revenue. Analysts had been expecting earnings of 49 cents per share on…
Amgen Inc (AMGN) has filed a lawsuit against Sanofi (SNY ) and Regeneron Pharmaceuticals, Inc. (REGN) in the U.S. District Court of Delaware. The lawsuit is related to the infringement of certain patents (patent numbers 8,563,698, 8,829,165, and 8,859,741) owned by Amgen which describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9)….
